Skip to content

Clinical trials

Cholangiocarcinoma trials in Austria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cholangiocarcinoma Country / region: Austria Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20142
20161
20191
20201
20212
20221
20232
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting3
Completed3
Recruiting2
Terminated2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie1
Amgen1
Incyte Corporation1
Maastricht University1
Maastricht University Medical Center1
Medical University of Graz1
PrECOG, LLC.1
Servier Affaires Médicales1
TransThera Sciences (Nanjing), Inc.1
University Hospital Plymouth NHS Trust1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cholangiocarcinoma11
Carcinoma, Hepatocellular3
Bile Duct Neoplasms2
Pancreatic Neoplasms2
Triple Negative Breast Neoplasms2
Adenocarcinoma of Lung1
Breast Neoplasms1
Carcinoma, Merkel Cell1
Carcinoma, Non-Small-Cell Lung1
Carcinoma, Ovarian Epithelial1

Trials

Showing 76 to 11 of 11. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.